assurance maladie maternité – Remboursement des anti-migraineux de nouvelle génération

This written question asks the government about the reimbursement policy for new generation anti-migraine medications. It seeks clarification on the conditions and scope of coverage for these advanced treatments. The question affects patients suffering from migraines who are seeking access to innovative therapies. It also concerns healthcare providers and the national health insurance system regarding treatment costs.